| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5584812 | Practical Laboratory Medicine | 2017 | 8 Pages |
Abstract
The analytical performances of the Elecsys® Cyclosporine and Elecsys®Tacrolimus assays were acceptable. Furthermore, CyA and TAC concentrations may be simultaneously measured using a single pretreatment which is of benefit if patients have to undertake conversion between these two drugs. Additionally, it benefits the workflow in the clinical laboratory. Thus, the Elecsys® Cyclosporine and Elecsys® Tacrolimus assays may be suitable for routine therapeutic drug monitoring.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Clinical Biochemistry
Authors
Maki Sasano, Shigeki Kimura, Ikuhiro Maeda, Yoh Hidaka,